FENC
NASDAQ HealthcareFennec Pharmaceuticals Inc. - Common Stock
Biotechnology
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
๐ Market Data
| Price | $11.83 |
|---|---|
| Volume | 185,196 |
| Market Cap | 414.84M |
| Beta | 1.070 |
| RSI (14-Day) | 65.1 |
| 200-Day MA | $8.35 |
| 50-Day MA | $10.19 |
| 52-Week High | $13.25 |
| 52-Week Low | $5.65 |
| Forward P/E | 12.43 |
| Price / Book | 9.77 |
๐ฏ Investment Strategy Scores
FENC scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (71/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ Institutional Whale (10/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find FENC in your text
Paste any article, transcript, or post โ the tool will extract FENC and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.